All stock lists
Absci Corp (NASDAQ:ABSI)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
9.59+0.41 (+4.47%)
Insider Score
––Not scored
ABSI Insider Score
Insiders here have filed 4 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
ABSI analyst forecast
ABSI analyst consensus
Moderate Buy5 ratings
Buy 5 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
ABSI 12-month price target
$15.00+56.4% upsideaverage of 1 firm
$15.00High
$15.00Low
Best analysts covering ABSI
- Needham100%success rate · 4 calls
- JP Morgan100%success rate · 1 call
- HC Wainwright & Co.57%success rate · 14 calls
- Guggenheim50%success rate · 2 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
ABSI analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Keybanc | Overweight | — | — | Reiterated | 2026-10-16 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-10-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-10-12 |
| — | Needham | Buy | — | — | Reiterated | 2026-09-23 |
| BTIG | Buy | $15.00 | +70.1% | Reiterated | 2026-09-08 | |
| — | BTIG | Buy | — | — | Reiterated | 2026-08-12 |
| — | Needham | Buy | — | — | Reiterated | 2026-08-12 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-07-02 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-06-25 |
| — | BTIG | Buy | — | — | Reiterated | 2026-06-24 |
| — | Needham | Buy | — | — | Reiterated | 2026-06-24 |
| — | Guggenheim | Buy | — | — | Reiterated | 2026-06-15 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-05-08 |
| — | Needham | Buy | — | — | Reiterated | 2026-03-30 |
| — | Needham | Buy | — | — | Reiterated | 2026-03-25 |
| — | Needham | Buy | — | — | Reiterated | 2026-03-18 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-12-18 |
| — | Needham | Buy | — | — | Reiterated | 2025-12-12 |
| — | Needham | Buy | — | — | Reiterated | 2025-11-13 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-08-18 |
| — | Needham | Buy | — | — | Reiterated | 2025-08-13 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-07-28 |
| — | Needham | Buy | — | — | Reiterated | 2025-05-14 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-04-16 |
| — | Needham | Buy | — | — | Reiterated | 2025-04-09 |
| — | Guggenheim | Buy | — | — | Reiterated | 2025-03-20 |
| — | Needham | Buy | — | — | Reiterated | 2025-03-19 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-19 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-17 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-10 |
| — | Keybanc | Overweight | — | — | Reiterated | 2025-01-08 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-01-08 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-12-13 |
| — | Guggenheim | Buy | — | — | Reiterated | 2024-12-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-15 |
| — | Keybanc | Overweight | — | — | Reiterated | 2024-07-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-15 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-03-26 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-22 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-03-06 |
| — | Keybanc | Overweight | — | — | Reiterated | 2024-03-04 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-01-08 |
| — | Keybanc | Overweight | — | — | Reiterated | 2024-01-05 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-11-15 |
| — | Truist Securities | Buy | — | — | Reiterated | 2023-08-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-08-15 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2023-05-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-16 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-04 |
| — | Cowen & Co. | Outperform | — | — | Upgraded | 2022-08-12 |
| — | JP Morgan | Underweight | — | — | Downgraded | 2022-08-12 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2022-08-12 |
| — | Truist Securities | Buy | — | — | Reiterated | 2022-07-18 |
| — | Stifel | Hold | — | — | Reiterated | 2022-05-31 |
| — | Credit Suisse | Outperform | — | — | Reiterated | 2022-03-23 |
| — | Berenberg | Buy | — | — | Reiterated | 2022-02-01 |
| — | B of A Securities | Underperform | — | — | Downgraded | 2021-11-10 |
| — | B of A Securities | Neutral | — | — | Reiterated | 2021-08-16 |
| — | Stifel | Hold | — | — | Reiterated | 2021-08-16 |
ABSI earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-24 | -0.16 | -0.23 | $1.3M | $650K |
| 2026-05-07 | -0.20 | -0.19 | $1.3M | $215K |
| 2026-08-11 | -0.19 | -0.18 | $920K | $300K |
| 2026-11-12 | -0.19 | 0.00 | $664K | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.